Next-Gen Obesity Drugs: China's Innovative Leap
Kilder
- Nature: Obesity drugs made in China could power next wave of treatments - Nature
- Nature: A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular anti-sense oligonucleotide activity - Nature
- Nature: International partnership for governing generative artificial intelligence models in medicine - Nature
- Fiercebiotech: Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 - Fierce Biotech
- Bioworld: China clears mazdutide as first dual GCG/GLP-1RA for weight loss - BioWorld MedTech
- Nature: Precision gene editing medicine makes history, and it’s just getting started - Nature
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.